TPI-1
CAS: 79756-69-7
Ref. 3D-EDA75669
| 1g | Descatalogado | ||
| 2g | Descatalogado | ||
| 5g | Descatalogado | ||
| 5mg | Descatalogado | ||
| 10mg | Descatalogado | ||
| 25mg | Descatalogado | ||
| 50mg | Descatalogado | ||
| 100mg | Descatalogado | ||
| 250mg | Descatalogado | ||
| 500mg | Descatalogado |
Información del producto
Nombre:
TPI-1
Descripción:
TPI-1 is a HDAC inhibitor that has shown to have an apoptotic effect on cancer cells. It inhibits the production of reactive oxygen species, leading to cell death. TPI-1 may inhibit gene transcription by binding to the protein phosphatase and inhibiting its activity. TPI-1 has been shown to have a primary tumor growth inhibitory effect in mouse models of breast cancer and cervical cancer. TPI-1 induces apoptosis in human cervical cancer cells. It also induces apoptosis in rat primary tumors implanted subcutaneously in athymic mice, with no observed toxicity.
Aviso:
Nuestros productos están destinados únicamente para uso en laboratorio. Para cualquier otro uso, por favor contáctenos.
Marca:
Biosynth
Almacenamiento de larga duración:
Notas:
Propiedades químicas
Peso molecular:
253.08 g/mol
Fórmula:
C12H6Cl2O2
Pureza:
Min. 95%
MDL:
Punto de fusión:
Punto de ebullición:
Punto de inflamabilidad:
Densidad:
Concentración:
EINECS:
Merck:
Código HS:
